Skip to main content
Premium Trial:

Request an Annual Quote

PreventionGenetics to Integrate FDNA's Face2Gene Into DNA Testing Services

CHICAGO (GenomeWeb) – PreventionGenetics, a CLIA-certified DNA testing laboratory, said today that it has integrated its testing and interpretation services with with FDNA's Face2Gene next-generation phenotyping application suite.

Face2Gene uses facial analysis, deep learning, and artificial intelligence to evaluate symptoms of patients with rare genetic diseases and suggest possible diagnoses, based on a database of more than 10,000 rare disease syndromes. Marshfield, Wisconsin-based PreventionGenetics said this integration would help improve the diagnostic ability of its testing by finding genetic variants relevant to specific diseases and each patient's clinical phenotype.

"Bringing FDNA's artificial intelligence and facial analysis technologies to PreventionGenetics and other leading labs is facilitating a new age in precision medicine," FDNA CEO Dekel Gelbman said in a statement. "With this integration, clinicians can identify malfunctioning genetics for their patients faster, opening the door to therapy."

FDNA has struck other integration deals recently. In September, FDNA announced that it would integrate Face2Gene with AmbryPort 2.0, a clinical ordering system from Ambry Genetics.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.